Biotest AG (BIO)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Biotest AG (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012265
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biotest AG (Biotest) is a provider of pharmaceutical and biotherapeutic drugs which develops, manufactures and distributes biological medicines through its value chain from preclinical and clinical development to sales. Its main products comprise clotting factors, immunoglobulins, albumin and monoclonal antibodies in clinical development. The company specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest distributes its products through local marketing partners and distributors in Europe, North America, South America, Asia, the Middle East and Africa. It has subsidiaries and sales companies in Austria, Switzerland, France, Great Britain, Italy, Hungary, Spain and in Brazil. Biotest is headquartered in Dreieich, Hessen, Germany.

Biotest AG (BIO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biotest AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Biotest AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Biotest AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Biotest AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Biotest AG, Medical Devices Deals, 2011 to YTD 2017 9
Biotest AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Biotest AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Biotest Pharma Enters into Distribution Agreement with Kedrion Biopharma 11
Biotest Enters Into Research Agreement With EpiVax 12
Biotest Enters Into Co-Marketing Agreement With Merz Pharma And Vianex 13
Biotest Enters Into Distribution Agreement With Wanbang Biopharma For Human Serum Albumin 14
Abbott Labs Enters Into Co-Development Agreement With Biotest For BT-061 15
Licensing Agreements 17
Adma Biologics Amends Licensing Agreement With Biotest For IGIV 17
CEVEC Pharma Enters into Licensing Agreement with Biotest 18
Affibody Enters into Licensing Agreement with Biotest 19
Adma Biologics Enters Into Licensing Agreement With Biotest Pharma For RSV Immune Globulin 20
Adma Biologics Enters Into Licensing Agreement With Biotest For Varicella Zoster Immune Globulin 21
Equity Offering 22
Biotest Completes Rights Offering Of Preference Shares For US$99.5 Million 22
Asset Transactions 23
ADMA Biologics Acquires Certain Assets from Biotest Pharma 23
Acquisition 25
Biotest Acquires Marcos Pedrilson Produtos Hospitalares 25
Biotest AG – Key Competitors 26
Biotest AG – Key Employees 27
Biotest AG – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 31
Financial Announcements 31
May 12, 2016: Biotest increases EBIT significantly in the first quarter 2016 31
Mar 23, 2016: Biotest: Increase of guidance 2016 by more than 10% 32
Feb 11, 2016: Biotest exceeds EBIT guidance for 4th quarter 2015 33
Legal and Regulatory 34
Apr 07, 2016: Biotest opens fourth plasma collection centre in Hungary 34
Other Significant Developments 35
Oct 11, 2017: Biotest strengthens its position in the German haemophilia market with the introduction of new patient support services 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Biotest AG, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Biotest AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Biotest AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Biotest AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Biotest AG, Deals By Therapy Area, 2011 to YTD 2017 8
Biotest AG, Medical Devices Deals, 2011 to YTD 2017 9
Biotest AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Biotest Pharma Enters into Distribution Agreement with Kedrion Biopharma 11
Biotest Enters Into Research Agreement With EpiVax 12
Biotest Enters Into Co-Marketing Agreement With Merz Pharma And Vianex 13
Biotest Enters Into Distribution Agreement With Wanbang Biopharma For Human Serum Albumin 14
Abbott Labs Enters Into Co-Development Agreement With Biotest For BT-061 15
Adma Biologics Amends Licensing Agreement With Biotest For IGIV 17
CEVEC Pharma Enters into Licensing Agreement with Biotest 18
Affibody Enters into Licensing Agreement with Biotest 19
Adma Biologics Enters Into Licensing Agreement With Biotest Pharma For RSV Immune Globulin 20
Adma Biologics Enters Into Licensing Agreement With Biotest For Varicella Zoster Immune Globulin 21
Biotest Completes Rights Offering Of Preference Shares For US$99.5 Million 22
ADMA Biologics Acquires Certain Assets from Biotest Pharma 23
Biotest Acquires Marcos Pedrilson Produtos Hospitalares 25
Biotest AG, Key Competitors 26
Biotest AG, Key Employees 27
Biotest AG, Other Locations 28
Biotest AG, Subsidiaries 29

★海外企業調査レポート[Biotest AG (BIO)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Reliance Industries Limited:戦略・SWOT・企業財務分析
    Reliance Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • JSHP Transformer Co Ltd:企業の戦略的SWOT分析
    JSHP Transformer Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Axela Inc-医療機器分野:企業M&A・提携分析
    Summary Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and …
  • InteRNA Technologies BV-製薬・医療分野:企業M&A・提携分析
    Summary InteRNA Technologies BV (InteRNA) is a biotechnology company that specializes in the development of RNA therapeutics for the treatment of cancer. The company develops technologies in biomedical research translating miRNA sequence fields. Its drug development programs focuses on developing mi …
  • PCCW Limited:戦略・SWOT・企業財務分析
    PCCW Limited - Strategy, SWOT and Corporate Finance Report Summary PCCW Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Open Text Corporation:企業の戦略・SWOT・財務分析
    Open Text Corporation - Strategy, SWOT and Corporate Finance Report Summary Open Text Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Antibe Therapeutics Inc (ATE)-製薬・医療分野:企業M&A・提携分析
    Summary Antibe Therapeutics Inc (Antibe) is a biotechnology company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercialize novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen …
  • Human Care HC AB:企業の戦略的SWOT分析
    Human Care HC AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Philippine Long Distance Telephone Company:企業の戦略・SWOT・財務情報
    Philippine Long Distance Telephone Company - Strategy, SWOT and Corporate Finance Report Summary Philippine Long Distance Telephone Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Gfk SE (GFK):企業の財務・戦略的SWOT分析
    Summary GfK SE (GfK) is a business service provider that offers market and consumer services. The company provides solutions such as online pricing intelligence, brand and customer experience, point of sales analytics, digital marketing intelligence, consumer panels, product catalogs, market opportu …
  • Novozymes AS (NZYM B):企業の財務・戦略的SWOT分析
    Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Intarcia Therapeutics Inc-医療機器分野:企業M&A・提携分析
    Summary Intarcia Therapeutics Inc (Intarcia), formerly BioMedicines Inc, is a biopharmaceutical company that discovers, develops and commercializes drug therapies to reduce effects for chronic diseases. The company’s product candidate include ITCA 650, which is in Phase III clinical trial. Its ITCA …
  • Quadra – Power Generation (TGKD):電力:M&Aディール及び事業提携情報
    Summary Quadra - Power Generation (Quadra) is an electric utility. It generates electricity and sells that on wholesale basis and in capacity market; and produces, transports, and sells thermal energy on retail market. The company has production facilities in Lipetsk, Voronezh, Tambov, Kursk, Belgor …
  • Solon Eiendom ASA (SOLON):企業の財務・戦略的SWOT分析
    Solon Eiendom ASA (SOLON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PTT Public Co Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    PTT Public Co Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary PTT Public Co Ltd (PTT) is a state-owned integrated national oil and gas, and petrochemical company. It operates in oil and natural gas, coal, power, and infrastructure businesses. The company carr …
  • Nelnet, Inc.:企業の戦略・SWOT・財務情報
    Nelnet, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nelnet, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • National Gas & Industrial Co (2080):企業の財務・戦略的SWOT分析
    National Gas & Industrial Co (2080) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Navistar International Corp (NAV):企業の財務・戦略的SWOT分析
    Navistar International Corp (NAV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Savara Inc (SVRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Savara Inc (Savara) formerly Mast Therapeutics Inc is a clinical stage biopharmaceutical company, which develops therapies for the treatment of rare respiratory diseases, including cystic fibrosis (CF), and pulmonary alveolar proteinosis (PAP). The company’s lead product candidates include M …
  • Iberdrola, S.A.:企業の戦略・SWOT・財務情報
    Iberdrola, S.A. - Strategy, SWOT and Corporate Finance Report Summary Iberdrola, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆